116 related articles for article (PubMed ID: 25816779)
1. Proteinase K and the structure of PrPSc: The good, the bad and the ugly.
Silva CJ; Vázquez-Fernández E; Onisko B; Requena JR
Virus Res; 2015 Sep; 207():120-6. PubMed ID: 25816779
[TBL] [Abstract][Full Text] [Related]
2. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
Wang F; Wang X; Abskharon R; Ma J
Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
[TBL] [Abstract][Full Text] [Related]
3. Quaternary Structure Changes for PrP
Eskandari-Sedighi G; Cortez LM; Yang J; Daude N; Shmeit K; Sim V; Westaway D
Mol Neurobiol; 2021 Jan; 58(1):375-390. PubMed ID: 32959170
[TBL] [Abstract][Full Text] [Related]
4. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
5. Structural features of prions explored by sequence analysis. II. A PrP(Sc) model.
Mornon JP; Prat K; Dupuis F; Boisset N; Callebaut I
Cell Mol Life Sci; 2002 Dec; 59(12):2144-54. PubMed ID: 12568340
[TBL] [Abstract][Full Text] [Related]
6. Assessing proteinase K resistance of fish prion proteins in a scrapie-infected mouse neuroblastoma cell line.
Salta E; Kanata E; Ouzounis CA; Gilch S; Schätzl H; Sklaviadis T
Viruses; 2014 Nov; 6(11):4398-421. PubMed ID: 25402173
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a combinatorial approach to prion inactivation using an oxidizing agent, SDS, and proteinase K.
Smith JD; Nicholson EM; Greenlee JJ
BMC Vet Res; 2013 Jul; 9():151. PubMed ID: 23886483
[TBL] [Abstract][Full Text] [Related]
8. Toward the Atomic Structure of PrP
Rodriguez JA; Jiang L; Eisenberg DS
Cold Spring Harb Perspect Biol; 2017 Sep; 9(9):. PubMed ID: 28096267
[TBL] [Abstract][Full Text] [Related]
9. The Unexposed Secrets of Prion Protein Oligomers.
Wang G; Wang M; Li C
J Mol Neurosci; 2015 Aug; 56(4):932-937. PubMed ID: 25823438
[TBL] [Abstract][Full Text] [Related]
10. Neurodegenerative diseases: expanding the prion concept.
Walker LC; Jucker M
Annu Rev Neurosci; 2015 Jul; 38():87-103. PubMed ID: 25840008
[TBL] [Abstract][Full Text] [Related]
11. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of phenotypic diversity and replication rate of human prions.
Safar JG; Xiao X; Kabir ME; Chen S; Kim C; Haldiman T; Cohen Y; Chen W; Cohen ML; Surewicz WK
PLoS Pathog; 2015 Apr; 11(4):e1004832. PubMed ID: 25875953
[TBL] [Abstract][Full Text] [Related]
13. The Structure of PrP
Wille H; Requena JR
Pathogens; 2018 Feb; 7(1):. PubMed ID: 29414853
[TBL] [Abstract][Full Text] [Related]
14. Circulation of prions within dust on a scrapie affected farm.
Gough KC; Baker CA; Simmons HA; Hawkins SA; Maddison BC
Vet Res; 2015 Apr; 46(1):40. PubMed ID: 25889731
[TBL] [Abstract][Full Text] [Related]
15. Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease.
Bouybayoune I; Mantovani S; Del Gallo F; Bertani I; Restelli E; Comerio L; Tapella L; Baracchi F; Fernández-Borges N; Mangieri M; Bisighini C; Beznoussenko GV; Paladini A; Balducci C; Micotti E; Forloni G; Castilla J; Fiordaliso F; Tagliavini F; Imeri L; Chiesa R
PLoS Pathog; 2015 Apr; 11(4):e1004796. PubMed ID: 25880443
[TBL] [Abstract][Full Text] [Related]
16. The safety of the blood supply--time to raise the bar.
Snyder EL; Stramer SL; Benjamin RJ
N Engl J Med; 2015 May; 372(20):1882-5. PubMed ID: 25902384
[No Abstract] [Full Text] [Related]
17. Cavitation during the protein misfolding cyclic amplification (PMCA) method--The trigger for de novo prion generation?
Haigh CL; Drew SC
Biochem Biophys Res Commun; 2015 Jun; 461(3):494-500. PubMed ID: 25892519
[TBL] [Abstract][Full Text] [Related]
18. Interaction between Shadoo and PrP Affects the PrP-Folding Pathway.
Ciric D; Richard CA; Moudjou M; Chapuis J; Sibille P; Daude N; Westaway D; Adrover M; Béringue V; Martin D; Rezaei H
J Virol; 2015 Jun; 89(12):6287-93. PubMed ID: 25855735
[TBL] [Abstract][Full Text] [Related]
19. Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease.
Cramm M; Schmitz M; Karch A; Mitrova E; Kuhn F; Schroeder B; Raeber A; Varges D; Kim YS; Satoh K; Collins S; Zerr I
Mol Neurobiol; 2016 Apr; 53(3):1896-1904. PubMed ID: 25823511
[TBL] [Abstract][Full Text] [Related]
20. Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications.
Maheshwari A; Fischer M; Gambetti P; Parker A; Ram A; Soto C; Concha-Marambio L; Cohen Y; Belay ED; Maddox RA; Mead S; Goodman C; Kass JS; Schonberger LB; Hussein HM
Emerg Infect Dis; 2015 May; 21(5):750-9. PubMed ID: 25897712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
